Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,786
Closed -$263K 128
2026
Q1
$263K Sell
1,786
-190
-10% -$30.9K 0.07% 100
2025
Q4
$385K Buy
1,976
+293
+17% +$69.8K 0.1% 95
2025
Q3
$473K Sell
1,683
-72
-4% -$18.3K 0.18% 60
2025
Q2
$384K Buy
1,755
+29
+2% +$4.68K 0.16% 59
2025
Q1
$241K Sell
1,726
-8
-0.5% -$1.3K 0.11% 77
2024
Q4
$289K Buy
1,734
+67
+4% +$11.9K 0.12% 74
2024
Q3
$284K Sell
1,667
-34
-2% -$4.92K 0.12% 66
2024
Q2
$240K Buy
1,701
+6
+0.4% +$745 0.11% 63
2024
Q1
$213K Buy
+1,695
New +$194K 0.11% 63
2023
Q4
Sell
-2,018
Closed -$214K 83
2023
Q3
$214K Buy
2,018
+333
+20% +$38.5K 0.13% 66
2023
Q2
$201K Buy
+1,685
New +$174K 0.12% 56

Other funds holding ORCL

WorthPointe's ORCL Position: Q2 2026 in Review

WorthPointe sold out of Oracle (ORCL) in Q2 2026, closing a stake of 1,786 shares — an estimated $263K sold.

WorthPointe first reported a position in ORCL in Q2 2023 and held it in 11 quarters. The position peaked at $473K in Q3 2025. 1,671 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • WorthPointe reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
  • WorthPointe sold 1,786 Oracle shares in Q2 2026, an estimated $263K.
  • WorthPointe first reported a position in Oracle in Q2 2023 and held it in 11 quarters.
  • WorthPointe's Oracle position peaked at $473K in Q3 2025.
  • 1,671 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on WorthPointe's 13F filing for Q2 2026, filed 31 Jul 2026.